Immunohistochemical expression of PD-L1 and MDR1 in breast tumors: association with clinico-pathological parameters and treatment outcome-Reference-Cited by-同舟云学术

Immunohistochemical expression of PD-L1 and MDR1 in breast tumors: association with clinico-pathological parameters and treatment outcome

Published:2022-07-09 Issue: Volume: Page:
ISSN:1591-9528
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Antony Gisha Rose,Augustine Paul,Parambil Sulfath Thottungal,Littleflower Ajeesh Babu,Kattoor Jayasree,Krishna K. M. Jagathnath,Subhadradevi Lakshmi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10238-022-00852-x.pdf

Reference47 articles.

1. Al-Thoubaity FK. Molecular classification of breast cancer: A retrospective cohort study. Ann Med Surg. 2020;49:44–8.

2. Kaboli PJ, Salimian F, Aghapour S, et al. Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer–A comprehensive review from chemotherapy to immunotherapy. Pharmacol Res. 2020;156: 104806.

3. Thike AA, Cheok PY, Jara-Lazaro AR, Tan B, Tan P, Tan PH. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol. 2010;23:123–33.

4. Hartkopf AD, Taran FA, Wallwiener M, et al. PD-1 and PD-L1 immune checkpoint blockade to treat breast cancer. Breast Care. 2016;11:385–90.

5. Bischoff J. Checkpoint inhibitors in breast cancer-current status and future directions. Breast care. 2018;13:27–31.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of PD-1/PD-L1 signaling pathway in cancer pathogenesis and treatment: a systematic review;Journal of Cancer Metastasis and Treatment;2024-05-28

2. Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling;Cancer and Metastasis Reviews;2023-10-04

3. PD-1/PD-L1 blockade inhibits epithelial-mesenchymal transition and improves chemotherapeutic response in breast cancer;Medical Oncology;2023-02-26